Roivant Sciences (ROIV) revenue breakdown

Healthcare · Biotechnology · Market cap $27.2B

By product, Product revenue, net is the largest at 60% of fiscal 2024 revenue, growing 168% a year over 1 years.

Revenue by product

Fiscal years, as Roivant Sciences reports them in its 10-K filings; fiscal 2024 total $125M.

Products20232024Share
Product revenue, net$28M$75M 60%
License, milestone and other revenue$33M$50M 40%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ROIV.
Open ROIV in Investingly

Questions

Where does Roivant Sciences make its money?

In fiscal 2024, by product: Product revenue, net $75M, License, milestone and other revenue $50M.

From Roivant Sciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.